Inflammatory mechanisms play a key role in the pathogenesis of type 1 diabetes. Individuals who progress to type 2 diabetes display features of low-grade inflammation years in advance of disease onset. This low-grade inflammation has been proposed to be involved in the pathogenetic processes causing type 2 diabetes. Mediators of inflammation such as tumor necrosis factor-␣, interleukin (IL)-1, the IL-6 family of cytokines, IL-18, and certain chemokines have been proposed to be involved in the events causing both forms of diabetes. IL-6 has in addition to its immunoregulatory actions been proposed to affect glucose homeostasis and metabolism directly and indirectly by action on skeletal muscle cells, adipocytes, hepatocytes, pancreatic -cells, and neuroendocrine cells. Here we argue that IL-6 action-in part regulated by variance in the IL-6 and IL-6␣ receptor genes-contributes to, but is probably neither necessary nor sufficient for, the development of both type 1 and type 2 diabetes. Thus, the two types of diabetes are also in this respect less apart than apparent. However, the mechanisms are not clear, and we therefore propose future directions for studies in this field. Diabetes 54 (Suppl. 2):S114 -S124, 2005 S ince ancient Greece, differences in lethality and distinct clinical features have led physicians to discern between two main diabetic phenotypes. But it has only been since 1974 that what we now know as type 1 and type 2 diabetes could be objectively distinguished by their different associations to genes in the major histocompatibility complex (1). In the past 30 years, much effort has been devoted to prove the nosological differences between the two disease entities in terms of environmental, genetic, and pathogenetic features. In the last decade, the interest for the role of inflammation in a wide range of diseases not commonly regarded as immune-mediated disorders, such as atherosclerosis and adiposity, has fostered studies that indicate that inflammatory mediators may not only be markers of metabolic aberrancies in type 2 diabetes, but may directly contribute to -cell dysfunction and insulin resistance (2,3).Type 1 diabetes is characterized by a complete or near-complete insulin deficiency caused by an immunemediated selective destruction of the insulin-producing -cells in the islets of Langerhans. Type 1 diabetes can be considered an inflammatory disease of the pancreatic islets in which a process of programmed cell death (apoptosis) is elicited in the -cells by interaction of activated T-cells and proinflammatory cytokines in the immune infiltrate (4). The immune-mediated -cell destruction is thought to be initiated by interaction between yet unknown environmental factors and type 1 diabetes susceptibility gene variants (5).Type 2 diabetes is characterized by the failure of the -cells to compensate for peripheral insulin resistance (6). Within the last decade, an increasing body of evidence has accumulated in favor of a putative role of immuno-related mechanisms and factors in the pathogene...